Physician profile
Peter R Bumanis
NPI 1962499731
$4,020.97
in general payments reported to CMS, 2019-2025
18 companies · $43.11 in 2025
The $43.11 reported for 2025 was less than what a typical Anesthesiology provider received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18.95 · 2020: $20.87 · 2021: $532 · 2022: $1,189 · 2023: $1,919 · 2024: $298 · 2025: $43.11.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,260.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,260.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $1,446.86 | 2019-2025 | Xifaxan, Trulance |
| Abbvie INC. | $1,226.32 | 2021-2024 | Rinvoq, Skyrizi |
| Takeda Pharmaceuticals U.S.A., INC. | $479.82 | 2021-2024 | Entyvio |
| Janssen Biotech, INC. | $246.50 | 2022-2024 | Stelara, Tremfya |
| Genzyme Corporation | $164.44 | 2022-2023 | |
| Merck Sharp & Dohme LLC | $82.48 | 2022-2024 | Dificid |
| Amgen INC. | $53.50 | 2023 | Amjevita, Avsola |
| Ironwood Pharmaceuticals, INC | $52.55 | 2023 | Linzess |
| Intercept Pharmaceuticals, INC. | $49.44 | 2023 | Ocaliva |
| Regeneron Healthcare Solutions, INC. | $45.55 | 2022-2023 | Dupixent |
| Ferring Pharmaceuticals INC. | $28.19 | 2023 | Rebyota |
| Nestle Healthcare Nutrition INC. | $27.32 | 2022 | |
| Alnylam Pharmaceuticals INC. | $25.54 | 2021 | |
| Conmed Corporation | $23.16 | 2025 | Conmed Generators, Conmed Biliary, Conmed Hemostasis |
| Galderma Laboratories, L.P. | $18.50 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Apollo Endosurgery US INC | $17.57 | 2023 | Overstitch Endoscopic Suturing System |
| Pfizer INC. | $16.81 | 2021 | |
| Fresenius Kabi USA, LLC | $16.42 | 2023 | Idacio |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Bumanis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.